Jennison Associates’s Aratana Therapeutics, Inc. PETX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-975,369
| Closed | -$5.17M | – | 669 |
|
|
2017
Q1 | $5.17M | Sell |
975,369
-171,558
| -15% | -$909K | 0.01% | 505 |
|
|
2016
Q4 | $8.24M | Sell |
1,146,927
-75,080
| -6% | -$539K | 0.01% | 488 |
|
|
2016
Q3 | $11.4M | Sell |
1,222,007
-1,637,927
| -57% | -$15.3M | 0.01% | 460 |
|
|
2016
Q2 | $18.1M | Sell |
2,859,934
-1,176,191
| -29% | -$7.43M | 0.02% | 408 |
|
|
2016
Q1 | $22.3M | Buy |
4,036,125
+17,690
| +0.4% | +$97.6K | 0.02% | 389 |
|
|
2015
Q4 | $22.4M | Sell |
4,018,435
-127,765
| -3% | -$713K | 0.02% | 406 |
|
|
2015
Q3 | $35.1M | Buy |
4,146,200
+714,413
| +21% | +$6.04M | 0.04% | 358 |
|
|
2015
Q2 | $51.9M | Buy |
3,431,787
+311,738
| +10% | +$4.71M | 0.05% | 331 |
|
|
2015
Q1 | $50M | Sell |
3,120,049
-13,659
| -0.4% | -$219K | 0.05% | 329 |
|
|
2014
Q4 | $55.8M | Buy |
3,133,708
+57,943
| +2% | +$1.03M | 0.05% | 307 |
|
|
2014
Q3 | $30.9M | Buy |
3,075,765
+638,761
| +26% | +$6.41M | 0.03% | 397 |
|
|
2014
Q2 | $38M | Buy |
2,437,004
+529,147
| +28% | +$8.26M | 0.04% | 362 |
|
|
2014
Q1 | $35.4M | Buy |
1,907,857
+498,721
| +35% | +$9.26M | 0.03% | 379 |
|
|
2013
Q4 | $26.9M | Buy |
1,409,136
+979,183
| +228% | +$18.7M | 0.03% | 413 |
|
|
2013
Q3 | $7.03M | Buy |
429,953
+4,953
| +1% | +$80.9K | 0.01% | 490 |
|
|
2013
Q2 | $3.21M | Buy |
+425,000
| New | +$3.21M | ﹤0.01% | 504 |
|